Oui Therapeutics is built on science shown to help people manage troubling thoughts.
Oui Therapeutics has raised $26.0M in total funding. The most recent round was Series A. The last funding was announced in August 2022.
Oui Therapeutics's investors include First Round Capital, Polaris Partners, CVS Health, Flare Capital Partners, Otsuka Holdings.
Oui Therapeutics is headquartered in New Haven, United States.
Oui Therapeutics is built on science shown to help people manage troubling thoughts.
Oui Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oui Therapeutics — Funding & Investors." VCBacked, August 2, 2022, https://www.vcbacked.co/company/oui-therapeutics. Accessed November 16, 2026.
VCBacked. (2022). Oui Therapeutics — Funding & Investors. Retrieved November 16, 2026, from https://www.vcbacked.co/company/oui-therapeutics
{{cite web |title=Oui Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/oui-therapeutics |website=VCBacked |access-date=November 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Oui Therapeutics? Request a listing update